Navigation Links
Reduced recognition of fear and sadness in post-traumatic stress disorder
Date:8/16/2011
s.
'/>"/>
| Contact: Laura Fabri l.fabri@elsevier.com 39-028-818-4302 Elsevier Source:Eurekalert |
Related medicine news :
1. Van Andel Research Institute finding could lead to reduced side effects in anti-cancer antibiotics
2. Lack of empathy following traumatic brain injury linked to reduced responsiveness to anger
3. FDA Urges Reduced Doses for Anemia Drugs
4. Rotavirus vaccine greatly reduced gastroenteritis hospitalizations in children
5. Bariatric surgery among older, high-risk patients not associated with reduced mortality
6. Aromasin Reduced Breast Cancer Risk in Postmenopausal Women
7. Study: Socioeconomics playing reduced role in autism diagnoses
8. New inhibitor prevented lesions, reduced tumor size in basal cell cancer
9. Life expectancy of severely mentally ill dramatically reduced due to poor physical health
10. Popular Bone Drugs Linked to Reduced Colon Cancer Risk
11. Researchers find reduced levels of an important neurotransmitter in MS
Post Your Comments:
(Date:6/19/2013)... R.I.) Casual, no-strings sexual encounters are increasingly ... more likely than others to "hook up"? A ... Centers for Behavioral and Preventive Medicine, published online ... suggests there are certain factors and behaviors associated ... , "Given the potential for negative emotional ...
(Date:6/19/2013)... for repairing damage to the genetic material DNA become ... seem, those compounds are sparking optimism as potential treatments ... in BRCA, a gene that made headlines when actress ... termed PARP inhibitors, are the topic of the cover ... Engineering News . C&EN is the weekly news magazine ...
(Date:6/19/2013)... Researchers at Moffitt Cancer Center and colleagues at Louisiana ... prostate cancers that require immediate therapy. It relies on ... The goal is to better predict a prostate cancer,s ... study was published in the online journal PLOS ... prostate cancer accounts for 20 percent of all cancers ...
(Date:6/19/2013)... Beverly Hills, CA (PRWEB) June 19, 2013 ... Beverly Hills, permits some patients to quit using drugs ... Kern and Adi Jaffe, the founders of Alternatives, believe ... “hit Bottom” before they enter treatment and that this ... that 22 million people in the United States need ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Many ... deem it medically necessary, according to a ... Child Health Journal. The results of this research ... more than a decade – that trying-to-conceive women ... maintaining a healthy body weight. Fairhaven Health is ...
Breaking Medicine News(10 mins):Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4[0] Why are some college students more likely to 'hook up'?[0] Renewed hope in a once-abandoned cancer drug class[0] Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers[0] Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment[0] Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies
... Lazard CEO Bruce Wasserstein comes under fire as ... care facilities value,private equity gain over safety measures; ... and Wasserstein greed, NEW YORK, July 7 ... launched an online campaign today to,bring attention to ...
... Scientists have identified a new antitumor drug that might ... cancers. The research, published by Cell Press in the ... , advances the understanding of one of the most ... provides new insight into the regulation of the complex ...
... staffing issues and geographic boundaries are some of the ... they plan for a possible influenza pandemic, according to ... health experts who are leading planning efforts for an ... counties, as defined by political lines," said George Avery, ...
... VirtualHealth,Technologies, Inc. (OTC Bulletin Board: VHGI) the ... Prescription Monitoring System announced,it,s support today of ... the electronic,prescribing of controlled substances., June ... would allow physicians to electronically prescribe controlled,substances. ...
... has been found to play a major role in,keeping ... hematopoietic,stem cells, MEMPHIS, Tenn., July 7 The ... run-of-the-mill enzyme that helps to,recycle molecules in cells causes ... St. Jude Children,s Research Hospital investigators., Children with ...
... wine, grape skins, inhibits abnormal cells, study finds , , ... in red grapes and red wine suppresses abnormal cell ... according to U.S. researchers. , The compound, resveratrol, is ... Breast cancer forms through a multi-stage process that differs ...
Cached Medicine News:Health News:Exploitation of Residents at Wasserstein and Lazard-linked Senior Care Facilities Exposed 2Health News:Bacterial peptide provides new insight into common tumor suppressor 2Health News:Political borders, health-care issues complicate pandemic planning 2Health News:Political borders, health-care issues complicate pandemic planning 3Health News:E-prescribing of Controlled Substances Moves Real-Time Prescription Drug Monitoring Toward Reality 2Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 2Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 3Health News:St. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood Disease 4Health News:Dietary Supplement May Prevent Breast Cancer 2Exploitation of Residents at Wasserstein and Lazard-linked Senior Care Facilities ExposedBacterial peptide provides new insight into common tumor suppressorPolitical borders, health-care issues complicate pandemic planningE-prescribing of Controlled Substances Moves Real-Time Prescription Drug Monitoring Toward RealitySt. Jude Study Reveals a New Function for an Old Enzyme in Fatal Childhood DiseaseDietary Supplement May Prevent Breast Cancer
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- In ... new specialty pharmaceutical company dedicated to advancing ... injectable and sustained release drug therapies in ... needs, today announced the acquisition of Enzon ... platform and associated product pipeline. Acquisition of ...
(Date:6/19/2013)... June 19, 2013 Pharma IQ is ... infographic summary of the results from an industry survey ... all respondents stated that CROs would be an area of ... will be running 6 or more clinical trials in the ... Trial Supply USA Summit explores the ...
(Date:6/18/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: ... that VPII Escrow Corp., a newly formed wholly owned ... of approximately $3.2 billion aggregate principal amount of senior ... in 2021 and in 2023, with final tranching determined ... the net proceeds from the offering, together with proceeds ...
Breaking Medicine Technology:Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3[0] Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies[0] Pharma IQ Presents the Latest Trends in Clinical Trial Supply[0] Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
... Pa., Oct. 27, 2011 ViroPharma Incorporated (NASDAQ: ... has signed a definitive agreement to acquire DuoCort ... Sweden focused on improving glucocorticoid replacement therapy. The ... ViroPharma,s orphan disease commercial product pipeline. The company ...
... Oct. 27, 2011 ViroPharma Incorporated (Nasdaq: VPHM ) ... 30, 2011. In the third quarter of 2011, we: ... representing 21 percent growth over the third quarter of 2010; ... quarter and $184 million for the 9 month period, representing Cinryze ...
Cached Medicine Technology:ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 2ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 3ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 4ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 5ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 6ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline 7ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 2ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 3ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 4ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 5ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 6ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 7ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 8ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 9ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 10ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 11ViroPharma Incorporated Reports Third Quarter 2011 Financial Results 12... versatility, and environmental safety are ... LE-80 K Ultracentrifuge from Beckman ... Optima centrifugation technology, the LE-80 ... effectively provide advanced capability for ...
... With the ability to provide a simple, ... in lipemic samples), the Airfuge CLS delivers ... can be cleaned in 10 minutes, eliminating ... tabletop centrifuge: Reaches top speed in as ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
... Microvolume technology , The ADVIA ... (as low as 2 L/test), reagent consumption ... consumption (25 L/hour) - thus maximizing management ... rapid, 3-second cycle and system throughput of ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |